• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Cytotoxic Drug Delivery - Product Image

Cytotoxic Drug Delivery

  • Published: May 2014
  • Greystone Associates

The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that – in spite of promising new drugs based on therapeutic antibodies – continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues.


- What are the key segments and addressable markets that comprise the market for cytotoxic drug delivery?
- What are the major therapeutic demand drivers for cytotoxic drug therapeutics?
- What are the design factors and technologies that are being used in commercial and development-stage closed drug transfer systems?
- What is the market READ MORE >

Executive Summary

The Executive Summary

Therapeutic Trends and Issues
The Administration of injectable/Infusable Antineoplastics
Drug Packaging and Administration Technology
Closed Drug Transfer – Driving Forces
Competitive Landscape
Risk Factors

Cytotoxic Drug Transfer Systems – The Current Generation

Key System Design Elements
Human Engineering/Ergonomics
Material Selection Issues
Drug Reconstitution and Dilution
Oncology Therapeutics Medication Safety
Oncology Drug Administration and Dosing
Drug-Specific Dosing Modification and Individualized Dosing

Closed Drug Transfer Commercial Device Assessments & Market Data

FDA Approved Products
Commercialized Non-FDA Approved Products
Closed Drug Transfer Component Suppliers

Market Factors

Regulatory Issues
Caregiver Compliance
Level of Complexity and Ease of Use
Healthcare Economics
Business Models and Strategies

Market Assessments and Forecasts

North America
Other Geographic Markets

Company Profiles

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos